Future MicrobiologyVol. 17, No. 13 CorrigendumFree AccessCorrigendumThis article is an Erratum ofEffectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patientsPublished Online:13 Jun 2022https://doi.org/10.2217/fmb-2022-0014c1AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View article"Corrigendum." Future Microbiology, 17(13), p. 1091FiguresReferencesRelatedDetailsCited ByComment on: ‘Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients’Esmeralda Garza-Santiago, Alejandro Ortiz-Hernández, Ashuin Kammar-García & Javier Mancilla-Galindo16 September 2022 | Future Microbiology, Vol. 17, No. 16Related articlesEffectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients9 Feb 2022Future Microbiology Vol. 17, No. 13 STAY CONNECTED Metrics Downloaded 518 times History Published online 13 June 2022 Published in print September 2022 Information© 2022 Future Medicine LtdPDF download